Start / The Long Run with Luke Timmerman / Ep134 emile nuwaysir on in vivo gene editing therapies

Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies

76 min • 24 april 2023

Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.

Kategorier

Förekommer på

00:00 -00:00